Generics - Pharmaceutical


Current filters:


Popular Filters

101 to 125 of 455 results

Win for copy drugmakers as US Supreme Court rules for generics in Bartlett pre-emption Case


In what must be seen as a major victory for the generic drug industry in the USA, the US Supreme Court,…

GenericsLegalNorth AmericaPharmaceutical

Waiver from European Commission to help exporting for US pharmaceutical manufacturers


The US Food and Drug Administration announced on Friday (June 21) that the USA is now a "listed country"…

EuropeGenericsNorth AmericaPharmaceuticalProductionRegulation

New study shows prices of IPHA firms' medicines in Ireland at European average


The prices of Irish Pharmaceutical Healthcare Association members' medicines in Ireland are now at the…


$200+ billion annual opportunity in USA from using medicines more responsibly, IMS finds


Avoidable costs of more than $200 billion are incurred each year in the US health care system as a result…

Antibiotics and Infectious diseasesDiabetesFinancialGenericsHealthcareNorth AmericaPharmaceutical

EU Commission fines Lundbeck and other Pharmas over "pay-for-delay" deals


In a much awaited decision following its investigations of patent settlements (or pay-for-delay deals)…

ActaviscitalopramEuropeFinancialGenericsLegalLundbeckMerck KGaAMylan LaboratoriesNeurologicalPatentsPharmaceuticalRanbaxy Laboratories

Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent


USA-based Actavis (NYSE: ACT), itself predominantly a generic drug marketer, and Japan's Kissei Pharmaceutical…

ActavisGenericsHetero GroupMen's HealthNorth AmericaNovartisPatentsPharmaceuticalRapaflo CapsulesSandoz

Negative US patent ruling for Novo Nordisk on Prandin


Denmark-based insulin giant Novo Nordisk (NOV: N) says that the US Court of Appeals for the Federal Circuit…

DiabetesGenericsLegalNovo NordiskPatentsPharmaceuticalPrandin

US Supreme Court says patent settlement can "sometimes" be illegal


In a long awaited ruling in the USA, the US Supreme Court yesterday (June 17) ruled in the patent settlement…

GenericsLegalNorth AmericaPatentsPharmaceutical

InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against


InSite Vision (OTC BB: INSV) that it will US pharma giants join Merck & CO (NYSE: MRK) and Pfizer (NYSE:…

AzaSiteGenericsInSite VisionLegalMerck & CoMylan LaboratoriesNorth AmericaOphthalmicsPatentsPfizerPharmaceutical

June meeting highlights from EMA Pharmacovigilance Risk Assessment Committee


The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has made several recommendations…


Generics triple-therapy just as effective as brand-name Enbrel, new study shows


Global biotech leader Amgen's (Nasdaq: AMGN) branded drug Enbrel (etanercept) is no more effective in…


China forms global alliance with Germany's blue inspection for drug quality


Effective June 1, 2013, the China Chamber of Commerce for Import & Export of Medicines & Health Products…


Irish Medicines Board drawing up list of generic drugs to help reduce costs


In Ireland, drugs to treat medical conditions such as high cholesterol, blood pressure and stomach ulcers…


Tightening health budgets on both sides of the Atlantic leading to crackdowns on patent settlements, says EIU analyst


Later this month, following an inquiry launched in 2009, the European Commission is expected to impose…

EuropeFinancialGenericsNorth AmericaPatentsPharmaceuticalPoliticsRegulation

Shire settles Intuniv patent infringement law suit against Teva concerning


Ireland-headquartered drugmaker Shire (LSE: SHP) has settled its litigation against the US subsidiary…

GenericsIntunivLegalNorth AmericaPatentsPharmaceuticalShireTeva Pharmaceutical Industries

CPhI Russia highlights growth in domestic manufacturing and international partnering


Presentations at the CPhI Russia event which took place in April reflected growth in the Russian pharma…


UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products


UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

Ireland passes legislation for reference pricing of drugs and increased generics use


Irish Parliamentarians last week passed the country's Health (Pricing and Supply of Medical Goods) Bill…


Russian government may change mechanism of price regulation for vital drugs


Sales of essential and vital drugs in Russia rose by 16% to 37.85 billion roubles ($1.21 billion) in…

EuropeGenericsMarkets & MarketingPharmaceuticalPricing

Government health care reforms foster development China's Pharma market, says F&S


Rising incomes, improving health care infrastructure and enhanced insurance systems have propelled the…

Asia-PacificGenericsHealthcareMarkets & MarketingPatentsPharmaceuticalPolitics

US Appeals Court puts temporary stop on sales of generics of AstraZeneca's Pulmicort Respules


Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced last Friday (May 24) that the US Court of Appeals…

ActavisAstraZenecaGenericsLegalMarkets & MarketingNorth AmericaPharmaceuticalPulmicort RespulesRespiratory and Pulmonary

101 to 125 of 455 results



Back to top